Postdoctoral Scientist in Translational Bioinformatics and Pharmacogenomics

The German Cancer Research Center (DKFZ) is one of Europe's largest cancer research centers. “Research for a life without cancer" is the mission of our world-class scientists and all our team members.

The DKFZ is a place where the brightest minds pursue bold ideas and seek answers to pioneering scientific questions through collaboration, innovation, and exploration across many disciplines. We provide a dynamic environment which empowers excellence with state-of-the-art technologies, cutting edge infrastructure, and a global scientific network.

Contribute your knowledge, vision, and dedication to create a space where scientific discovery in cancer research is transformed into benefits for human health.

The National Center for Tumor Diseases (NCT) is a long-term cooperation between the DKFZ, excellent partners in university medicine and other research institutions at six locations in Germany. The goal of the NCT is to bring promising results from cancer research into clinical application quickly and safely. This approach is intended to provide cancer patients with nationwide access to innovative treatment options.

One of the six NCT sites is the NCT Heidelberg, which is a collaboration between the DKFZ, the Heidelberg University Hospital (UKHD), the Heidelberg University and the Thoraxklinik Heidelberg.

We are seeking for the Molecular Precision Oncology Program at the National Center for Tumor Diseases and the German Cancer Research Center as of May 2026 a Postdoctoral Scientist in Translational Bioinformatics and Pharmacogenomics.

Reference number: 2026-0041